<html>
				<head>
				<title>D0728.max-reward-with-both-nws.system.html</title>
				</head>
				<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>Di Bisceglie said the antiviral drug interferon had reduced symptoms in up to 20 percent of patients with hepatitis C who were treated for six months . </a>
<a name="2">[2]</a> <a href="#2" id=2>In 1995 , when she first learned she was infected , Mrs. Buchanan enrolled in a study that provided six months of treatment with Robert Consalvo's 's version of the drug interferon , which eliminates the virus in 10 to 20 percent of patients . </a>
<a name="3">[3]</a> <a href="#3" id=3>The standard treatment is the drug interferon or a combination of interferon and ribavirin . </a>
<a name="4">[4]</a> <a href="#4" id=4>According to this week 's New England Journal of Medicine , six months after treatment , patients who received the two-drug combination were more likely to be free of hepatitis C than they would be if they accepted the traditional drug treatment of interferon . </a>
<a name="5">[5]</a> <a href="#5" id=5>The Food and Drug Administration on Wednesday approved a powerful combination of two antiviral drugs to treat chronic hepatitis C , a liver infection that can lead to cirrhosis , liver cancer and liver failure . </a>
<a name="6">[6]</a> <a href="#6" id=6>One , led by researchers at the Scripps Clinic and Research Foundation in La Jolla , Calif. , found that six months after treatment , a combination of interferon and a drug called ribavirin was 31 to 38 percent effective among patients being treated for the first time . </a>
<a name="7">[7]</a> <a href="#7" id=7>Rebetron , made by the Schering-Plough Corp. , was approved in June only for patients who had relapsed after taking interferon drugs , the only other approved treatment for the disease . </a>
</body>
				</html>
